药剂师在管理产前药物暴露中的角色和看法:一种定性研究
Fahad S Alshehri1,2, Nasser M Alorfi1,2, Ahmed M Ashour1,2
1Pharmacology and Toxicology Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
Medicine
|November 20, 2025
概括
药剂师在指导孕妇药物安全方面面临挑战,原因是知识差距和培训有限. 加强教育和资源可以改善它们在产前药物管理中的关键作用.
科学领域:
- 药理学和药房实践中的药理学和药房实践
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 质量健康研究 质量健康研究
背景情况:
- 怀孕期间安全使用药物对于母亲和胎儿的健康至关重要.
- 药剂师对于管理产前药物暴露,提供咨询和风险评估至关重要.
- 现有的知识差距,不一致的指导方针和患者的犹阻碍了药剂师有效的指导.
研究的目的:
- 调查药剂师对管理产前药物暴露的角色和挑战的看法.
- 确定影响药剂师就药物安全性向孕妇提供建议的能力的障碍和促进因素.
- 探索药剂师在产前药物治疗方面改善培训和资源的需求.
主要方法:
- 使用自主管理的在线调查进行定性研究设计.
- 有经验的药剂师在医院,心理健康和社区环境中为孕妇提供咨询服务.
- 基于布劳恩和克拉克框架的专题分析,以解释参与者的反应.
主要成果:
- 药剂师报告了有关产前药物管理的重大培训和知识差距.
- 确定的关键角色包括风险评估,患者咨询和专业间合作,尽管往往未得到充分利用.
- 挑战包括患者的恐惧,错误信息,缺乏标准化指导方针以及有限的最新资源.
结论:
- 药剂师对于产前药物安全至关重要,但面临着巨大的挑战.
- 加强培训计划,可访问的基于证据的资源和跨学科的合作是必不可少的.
- 未来的努力应优先考虑有针对性的教育,以加强药剂师在建议孕妇药物安全方面的专业知识.
更多相关视频
08:08Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model
Published on: June 18, 2013
17.8K
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
12.5K
相关概念视频
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
232
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
232
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
179
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
179
01:21Factors Affecting Drug Response: Overview
2.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
196
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
196
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
247
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
247